Neurotrope Announces Publication Highlighting the Potential of Bryostatin as a Unique Neurorestorative Therapy
NextTrip, Inc. (NTRP)
NASDAQ:AMEX Investor Relations:
neurotropebioscience.com/welcome_to_neurotrope_bioscience/investorsrelations.html
Company Research
Source: PR Newswire
NEW YORK, Aug. 13, 2019 /PRNewswire/ -- Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), today announced that an article highlighting the synaptic deficiency hypothesis was published online in Trends in Pharmacological Sciences. This article presents an overview of the previous nonpharmacological interventions and pharmacological agents, including Bryostatin, that target synaptic functions in order to improve cognitive functions against AD-related memory impairment. The publication emphasizes that restoring synaptic functions should be considered as one of the major therapeutic goals in the treatment of AD patients. "Alzheimer's disease, the leading disorder of memory impairment in our aging population, is increasing at an alarming rate and clinical trials targeting neurotoxic amyloid beta have consistently failed to produce therapeutic effects on memory functi
Show less
Read more
Impact Snapshot
Event Time:
NTRP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NTRP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NTRP alerts
High impacting NextTrip, Inc. news events
Weekly update
A roundup of the hottest topics
NTRP
News
- NextTrip's JOURNY Expands Global Reach with Launch on Apple iOS, Roku, and Android [Yahoo! Finance Canada]Yahoo! Finance Canada
- NextTrip (NASDAQ:NTRP) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Vanderbilt Report: How Gaming Veterans are Fixing Travel's $8 Billion Conversion Problem [Yahoo! Finance Canada]Yahoo! Finance Canada
- NextTrip signs LOI and enters exclusive discussions to acquire GoUSA TV platform [Seeking Alpha]Seeking Alpha
- NextTrip Signs Letter of Intent and Enters Exclusive Discussions to Acquire GoUSA TV Platform [Yahoo! Finance Canada]Yahoo! Finance Canada
NTRP
Sec Filings
- 12/4/25 - Form 8-K
- 11/28/25 - Form 8-K
- 11/25/25 - Form 4
- NTRP's page on the SEC website